Neutrophil-lymphocyte ratio in Crohn's disease patients predicts sustained response to infliximab 52-week therapy
- PMID: 25822447
Neutrophil-lymphocyte ratio in Crohn's disease patients predicts sustained response to infliximab 52-week therapy
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical